Síndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileiros

Página do item simplificado
dc.contributor.authorAloe, Flávio
dc.contributor.authorAlves, Rosana S Cardoso
dc.contributor.authorAndrade, Luiz Augusto Franco [UNIFESP]
dc.contributor.authorAssis,Márcia
dc.contributor.authorBacelar, Andrea
dc.contributor.authorBezerra, Márcio
dc.contributor.authorCardoso, Francisco [UNIFESP]
dc.contributor.authorFerraz, Henrique Ballalai [UNIFESP]
dc.contributor.authorFonseca, Ronaldo Guimarães
dc.contributor.authorHorta, Wagner
dc.contributor.authorHaddad, Mônica Santoro
dc.contributor.authorHasan, Rosa
dc.contributor.authorMattos, James Pitágoras
dc.contributor.authorPrado, Gilmar Fernandes do [UNIFESP]
dc.contributor.authorRizzo, Geraldo
dc.contributor.authorRodrigues, Nonato
dc.contributor.authorSilva, Ademir Batista da [UNIFESP]
dc.contributor.authorSilva, Delson Jose
dc.contributor.authorTeive, Helio Afonso Ghizoni
dc.contributor.authorGrupo Brasileiro de Estudos em Síndrome das Pernas Inquietas (GBE-SPI)
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionHosp Israelita Albert Einstein
dc.contributor.institutionPratica privada
dc.contributor.institutionPractica Privada
dc.contributor.institutionUniversidade Federal de Minas Gerais (UFMG)
dc.contributor.institutionUniversidade Federal de São Paulo (UNIFESP)
dc.contributor.institutionUFCE
dc.contributor.institutionUniversidade Federal de Goiás (UFG)
dc.date.accessioned2018-06-15T14:00:15Z
dc.date.available2018-06-15T14:00:15Z
dc.date.issued2007-09-01
dc.description.abstractThis article contains the conclusions of the November 17-18, 2006 meeting of the Brazilian Study Group of Restless Legs Syndrome (GBE-SPI) about diagnosis and management of restless legs syndrome (RLS). RLS is characterized by abnormal sensations mostly but not exclusively in the legs which worsen in the evening and are improved by motion of the affected body part. its diagnosis is solely based on clinical findings. Therapeutic agents with efficacy supported by Class I studies are dopamine agonists, levodopa and gabapentine. Class 11 studies support the use of slow release valproic acid, clonazepan and oxycoclone. The GBE-SPI recommendations for management of SPI are sleep hygiene, withdrawal of medications capable of worsening the condition, treatment of comorbidities and pharmacological agents. The first choice agents are dopaminergic drugs, second choice are gabapentine or oxycodone, and the third choice are clonazepan or slow release valproic acid.en
dc.description.affiliationUniv Sao Paulo, Hosp Clin, Dept Neurol, Sao Paulo, Brazil
dc.description.affiliationHosp Israelita Albert Einstein, Inst Cerebro, Sao Paulo, Brazil
dc.description.affiliationPratica privada, Curitiba, Parana, Brazil
dc.description.affiliationPractica Privada, Rio De Janeiro, Brazil
dc.description.affiliationUniv Fed Minas Gerais, Dept Clin Med, Belo Horizonte, MG, Brazil
dc.description.affiliationUniv Fed Sao Paulo, Escola Paulista Med, Dept Neurol, Sao Paulo, Brazil
dc.description.affiliationUNESP, Dept Neurol, Botucatu, SP, Brazil
dc.description.affiliationUFCE, Fortaleza, Ceara, Brazil
dc.description.affiliationPractica Privada, Porto Alegre, RS, Brazil
dc.description.affiliationUniv Fed Goias, Hosp Clin, Serv Neurol, Goiania, Go, Brazil
dc.description.affiliationUnifespUniv Fed Sao Paulo, Escola Paulista Med, Dept Neurol, Sao Paulo, Brazil
dc.description.sourceWeb of Science
dc.format.extent721-727
dc.identifierhttp://dx.doi.org/10.1590/S0004-282X2007000400035
dc.identifier.citationArquivos De Neuro-psiquiatria. Sao Paulo Sp: Assoc Arquivos Neuro- Psiquiatria, v. 65, n. 3A, p. 721-727, 2007.
dc.identifier.doi10.1590/S0004-282X2007000400035
dc.identifier.fileS0004-282X2007000400035.pdf
dc.identifier.issn0004-282X
dc.identifier.scieloS0004-282X2007000400035
dc.identifier.urihttp://repositorio.unifesp.br/handle/11600/42746
dc.identifier.wosWOS:000249453900035
dc.language.isopor
dc.publisherAssoc Arquivos Neuro- Psiquiatria
dc.relation.ispartofArquivos De Neuro-psiquiatria
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectrestless legs syndromeen
dc.subjectperiodic leg movementsen
dc.subjectsleepen
dc.subjectpramipexoleen
dc.subjectlevodopaen
dc.subjectdopamine agonistsen
dc.subjectgabapentineen
dc.subjectoxycodoneen
dc.subjectclonazepamen
dc.subjectslow release valproic aciden
dc.titleSíndrome das pernas inquietas: diagnóstico e tratamento. Opinião de especialistas brasileirospt
dc.title.alternativeRestless legs syndrome: diagnosis and treatment. Opinion of Brazilian expertsen
dc.typeinfo:eu-repo/semantics/article
Arquivos
Coleções
EPM - Artigos